Gastrointestinal stromal tumours: etiology, pathology and clinical management.
Blackstein
Martin E
ME
Mount Sinai Hospital, Toronto, Ontario. blackstein@utoronto.ca
Dubé
Pierre
P
Fletcher
Jonathan A
JA
Keller
Oliver R
OR
Knowling
Margaret
M
Létourneau
Richard
R
Morris
Donald
D
Riddell
Robert
R
Rorke
Stewart
S
Swallow
Carol J
CJ
D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001549:Benzamides / Q000494:pharmacology / Q000627:therapeutic use*; D016923:Cell Death; D002454:Cell Differentiation; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy / Q000473:pathology*; D046152:Gastrointestinal Stromal Tumors / Q000188:drug therapy / Q000473:pathology*; D006801:Humans; D000068877:Imatinib Mesylate; D009362:Neoplasm Metastasis; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use*; D011743:Pyrimidines / Q000494:pharmacology / Q000627:therapeutic use*; D015398:Signal Transduction
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate